Clinical Trials Logo
  1. Home
  2. Calciphylaxis
  3. NCT02854046

Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome — CalciWest  

Calciphylaxis Clinical Trial

Official title:
Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome : a Multicentric, Retrospective Cohort

Clinical Trial Summary

Calciphylaxis, also called Calcific Uremic Arteriolopathy (CUA) is a lethal affection mostly affecting patient in end stage renal disease. The survival rate is described around 20 to 46% at one year. Clinical presentation is very painful skin lesions with ulceration mostly located on the trunk or thigh. Current knowledge about physiopathology, diagnostic practice and therapeutic is very limited. Actually there is no European study about calciphylaxis and risk factors, diagnostic practice and outcome factors.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02854046
Study type Observational
Source Nantes University Hospital
Contact
Status Completed
Phase
Start date July 1, 2016
Completion date October 31, 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT01578382 - Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU)
Active, not recruiting NCT04592640 - Stem Cells for Uremic Calciphylaxis Patients N/A
Terminated NCT03319914 - Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate
Recruiting NCT06065852 - National Registry of Rare Kidney Diseases
Terminated NCT03150420 - A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients Phase 3
Completed NCT02790073 - Phase 2 Study With SNF472 in Calciphylaxis Patients Phase 2
Recruiting NCT03146793 - The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National Cohort N/A
Completed NCT02278692 - Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy N/A
Terminated NCT02527213 - Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopath Phase 3
Recruiting NCT03032835 - Partners Calciphylaxis Biobank
Completed NCT01289626 - Efficacy of Lanthanum Carbonate in Calciphylaxis Phase 1
Recruiting NCT06283589 - The SEAPORT 1 Study: Evaluation of the Safety and Tolerability of INZ-701 in Adults With End-Stage Kidney Disease Undergoing Hemodialysis Phase 1
Completed NCT04195906 - Phase 3 Study of SNF472 for Calciphylaxis Phase 3
Recruiting NCT02635373 - European Calciphylaxis Registry Network N/A
Recruiting NCT05018221 - Better Evidence and Translation for Calciphylaxis Phase 3